Literature DB >> 20598407

Molecular characterization of SG33 and Borghi vaccines used against myxomatosis.

Patrizia Cavadini1, Giuliana Botti, Ilaria Barbieri, Antonio Lavazza, Lorenzo Capucci.   

Abstract

Myxoma virus is a poxvirus responsible for myxomatosis in European Rabbits (Oryctolagus cuniculus). The entire genome of the myxoma virus has been sequenced, allowing a systemic survey of the functions of a large number of putative pathogenic factors that this virus expresses to subvert the immune and inflammatory pathways of infected rabbit hosts. In Italy, industrial rabbits are mostly vaccinated against myxomatosis using the attenuated myxoma virus strains Borghi or SG33. We have identified genetic markers specific for Borghi or SG33 vaccine strains and established a PCR-based assay that could be used to: (a) rapidly diagnose the presence of myxoma virus in infected organs; (b) discriminate between field strain-infected and vaccinated rabbits and (c) differentiate between Borghi or SG33 vaccine strain. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20598407     DOI: 10.1016/j.vaccine.2010.06.017

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Molecular methods in detection and epidemiologic studies of rabbit and hare viruses: a review.

Authors:  Ewa Kwit; Artur Rzeżutka
Journal:  J Vet Diagn Invest       Date:  2019-05-25       Impact factor: 1.279

2.  Detection of Myxoma Virus in the Classical Form of Myxomatosis Using an AGID Assay: Statistical Assessment of the Assay's Diagnostic Performance.

Authors:  Ewa Kwit; Zbigniew Osiński; Antonio Lavazza; Artur Rzeżutka
Journal:  J Vet Res       Date:  2020-07-14       Impact factor: 1.744

Review 3.  The current status and future directions of myxoma virus, a master in immune evasion.

Authors:  Bart Spiesschaert; Grant McFadden; Katleen Hermans; Hans Nauwynck; Gerlinde R Van de Walle
Journal:  Vet Res       Date:  2011-06-09       Impact factor: 3.683

4.  Genome sequence of SG33 strain and recombination between wild-type and vaccine myxoma viruses.

Authors:  Christelle Camus-Bouclainville; Magalie Gretillat; Robert Py; Jacqueline Gelfi; Jean Luc Guérin; Stéphane Bertagnoli
Journal:  Emerg Infect Dis       Date:  2011-04       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.